It’s likely that you’ve heard about the “Ozempic epidemic” – people using this anti-diabetic medication for their weight loss. 2 in 5 adults who use these medications use them solely to lose weight. This got to the point where there have been reported shortages of it, along with medications like Wegovy and Mounjaro, which also provide GLP-1.
Basically, Ozempic and similar medications work by increasing the levels of a hormone called GLP-1 (glucagon-like peptide 1), which slows digestion and makes a person feel full. This sensation enables a semi-permanent sensation of fullness, which leads a person to want to eat less and lose weight.
